Response Genetics, Inc
RGDXQ
$0.00
$0.000.00%
OTC PK
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -14.67% | -7.27% | -34.06% | -141.98% | -325.14% |
| Total Depreciation and Amortization | -7.10% | 6.37% | 26.19% | 47.42% | 50.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.90% | -3.19% | 136.27% | 260.52% | 157.69% |
| Change in Net Operating Assets | 92.56% | -1,840.27% | -218.48% | -48.52% | -66.33% |
| Cash from Operations | 39.25% | -262.49% | -63.56% | -63.09% | -251.58% |
| Capital Expenditure | 92.00% | 90.19% | 123.78% | 44.02% | 63.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | 88.55% | 29.71% | -229.55% |
| Cash from Investing | 94.62% | 92.87% | 114.39% | 40.07% | 48.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -20.21% | 43.69% | 9.26% | 0.80% | -22.45% |
| Issuance of Common Stock | -- | -100.00% | -100.00% | 450.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,795.71% | -100.64% | 380.29% | 1,032.31% | 22.70% |
| Foreign Exchange rate Adjustments | -25.68% | 3,322.22% | 342.86% | -- | -1,068.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.72% | -204.99% | 395.76% | -31.02% | -216.93% |